Filters close
Released: 22-Sep-2020 8:00 AM EDT
MEDIA ALERT: MSVirtual2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The MSVirtual2020 program will continue in an Encore Program that will be held on Saturday, September 26th from 9:00 a.m. – 12:15 p.m. ET. This Encore Program will feature the Late Breaker (9-10:30 a.m. ET) and COVID-19th (10:45 a.m. – 12:15 p.m. ET) sessions.

Released: 11-Sep-2020 6:15 PM EDT
Welcome Letter from ACTRIMS President on MSVirtual2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

It is with great pleasure that I welcome you to the 8th joint ACTRIMS-ECTRIMS conference. This conference, MSVirtual2020, is the largest conference dedicated to multiple sclerosis (MS) research and our first virtual conference.

Released: 9-Sep-2020 8:00 AM EDT
Registered Reporters Are Invited to Three Virtual MSVirtual2020 Press Conferences Featuring: The Latest Clinical Study Outcomes, Advances in Therapeutics, Diagnostics and Technologies, and Late Breakers and COVID-19 Impact on MS Research & Patient Care
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 8th Joint ACTRIMS-ECTRIMS meeting – the largest international conference focused on research in multiple sclerosis (MS), will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.

Released: 2-Sep-2020 9:00 AM EDT
The Facts About Multiple Sclerosis
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

In just the U.S. alone, more than 200 individuals are diagnosed with Multiple Sclerosis (MS) each week. However, when properly managed and controlled with medications and lifestyle adjustments, many of the common MS symptoms like visual and sensory loss, weakness and impared cognition can be mitigated.

Released: 2-Sep-2020 7:00 AM EDT
The 8th Joint ACTRIMS-ECTRIMS Meeting - MSVirtual2020 - To be Held September 11-13 With A Special Encore Session Featuring COVID-19 & MS and Late Breakers on September 26th
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.

Released: 13-Aug-2020 9:00 AM EDT
Largest International Multiple Sclerosis Research Conference in September 2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.

Released: 30-Jun-2020 8:00 AM EDT
8th Joint ACTRIMS-ECTRIMS (MSVirtual2020) Meeting to Be Held Virtually September 11-13, 2020 with an Encore Event on September 26th with Late Breakers and Special Session on COVID-19
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Registered media to MSVirtual2020 will have access to the full program including plenary sessions, invited speakers and platform presentations of abstracts, poster presentations, teaching courses, and industry supported satellite symposia, both scheduled and on-demand

Released: 29-Jun-2020 11:30 AM EDT
Letter from ACTRIMS President on MSVirtual2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

I am pleased to announce that the 8th Joint ACTRIMS-ECTRIMS Meeting will be held from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.

Released: 20-Feb-2020 4:30 PM EST
Neurology Professor from Harvard Medical School Wins Barancik Prize for Innovation in MS Research for Work Resulting in New Tools and Treatments to Combat MS
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Dr. Francisco J. Quintana to receive the award and deliver the Barancik Prize lecture at the ACTRIMS Forum 2020 for work resulting in new tools and treatments to combat MS

Released: 18-Feb-2020 3:25 PM EST
New Research Links Genetics and MS Severity, Offers Innovative Treatment Ideas to Combat MS and Other Neurodegenerative Diseases
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Dr. Peter Calabresi, professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center, will present his team’s discovery of a possible link between severe damage and C3 and C1q gene variants, and how this information could lead to improvements in the ways MS and other neurodegenerative diseases are treated, during his keynote Kenneth P. Johnson Memorial Lecture on the opening day of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020.

Released: 6-Dec-2019 4:50 PM EST
Networks in multiple sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2020 Forum
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Approximately 1,200 researchers and clinicians are expected to attend the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum Feb. 27-29, 2020, in West Palm Beach, Florida.

Released: 21-Jan-2019 3:05 PM EST
University of California Scientist Wins Barancik Prize for Innovation in MS Research
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Professor Katerina Akassoglou to receive 2018 Prize for work understanding the origins of nerve damage in MS and identifying potential therapies to stop it.

Released: 27-Nov-2018 4:55 PM EST
Tailored Disability-Specific Neuroprotective Treatment Development in MS Offers a Potential New Approach
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Dr. Rhonda Voskuhl professor at the University of California, Los Angeles, will present her hypothesis that molecular mechanisms underlying each disability may differ from each other based on regional differences in neurons, astrocytes and oligodendrocytes as the subject of the keynote Kenneth P. Johnson Memorial Lecture on the opening day of the ACTRIMS Forum 2019.

Released: 26-Feb-2018 12:05 PM EST
ACTRIMS Recognizes Young Investigators at Forum 2018
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) recognized the research contributions of five young investigators during the recent ACTRIMS Forum 2018. Abstracts and posters can be found in the ACTRIMS Forum online program, and will be published in the MS Journal.

Released: 14-Dec-2017 12:05 PM EST
Barancik Prize To Be Presented at ACTRIMS Forum 2018
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Professor Robin Franklin to receive the 2017 Barancik Prize for pioneering work to restore function for people with progressive MS. He will receive the award at ACTRIMS Forum 2018 on February 1 in San Diego, California.



close
0.52596